William T. Andrews - Aug 2, 2021 Form 4 Insider Report for Flexion Therapeutics Inc (FLXN)

Role
Chief Medical Officer
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Stock symbol
FLXN
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
4
Date filed
8/4/2021, 04:09 PM
Previous filing
Jul 6, 2021
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLXN Common Stock Award $0 +34.3K $0.00 34.3K Aug 2, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLXN Stock option (right to buy) Award $0 +206K $0.00 206K Aug 2, 2021 Common Stock 206K $6.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
F2 25% of the shares subject to the option shall vest on the one-year anniversary of July 1, 2021 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares subject to the options shall be vested four years after the Vesting Commencement Date.